CAITLYN HAYGOOD: Open Payments
NPI 1225781818 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 6 payments from 5 companies in 2025. Trend: 2023 $103 · 2024 $492 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $157 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| PFIZER INC. | 1 | $15 |
Products named: REPATHA, SHINGRIX, Dexcom G6 Transmitter, PREVNAR 20, OTEZLA.
Industry payments across GA — which companies pay providers there.
